According to Zhitong Finance App News, Bailong Chuangyuan (605016.SH) issued an announcement. Based on the development strategy plan and business development needs, the company invested in the establishment of a wholly-owned subsidiary, Bailong Chuangyuan (Kunming) Biotechnology Co., Ltd. in Kunming with its own capital of 10 million yuan. The company directly holds 100% of its shares. The investment aims to build a platform for Sino-Thai talent cooperation based on Kunming's location, channels and cultural advantages for Southeast Asia, target local and complex talents for Thai subsidiaries, and support the implementation of enterprise globalization strategies.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.